Quick facts
- A rapid strep test is a rapid antigen detection test (RADT) run on a throat swab and read during the visit; a culture is the slower confirmatory method.
- United States: group A Streptococcus appears on the FDA list of waived analytes, so a cleared rapid test can be run under a CLIA Certificate of Waiver.
- Canada: there is no federal "waived" category. The test is an in vitro diagnostic device requiring a device licence, and the testing site is licensed provincially.
- Packaging differs: Canada requires a means of containment made, selected and used to CAN/CGSB-43.125 (Type P650); the United States requires triple packaging under 49 CFR 173.199, a 1.2 m drop test, and the UN3373 diamond.
- The assay chemistry barely changes across the border. What changes is who may run the test, how the specimen is packaged, and what makes a specimen unacceptable.
A rapid strep test is one of the few point-of-care tests a clinic can run, report and act on inside a single visit. Because the assay is familiar, clinics assume the rules around it are familiar too. Two clinics running an identical test, one in Ontario and one in Ohio, sit under different device regimes, different transport laws and different acceptance criteria for the swab itself.
What is a rapid strep test, and where does it fit in the testing chain?
A rapid strep test, also written RADT, is an immunoassay that detects group A Streptococcus antigen directly from a throat swab. The swab is rubbed over the posterior pharynx and both tonsils, avoiding the tongue, teeth and buccal mucosa, then read after a short extraction step. The sequence takes minutes, which is the point: the clinician can decide on antibiotics before the patient leaves.
Two things about that workflow matter more than the strip. First, the swab is the specimen: it cannot be recollected from the same moment, it degrades in transit, and its quality depends on how it was taken. A swab that touched only the tongue looks identical to a good one once it is in the tube. Second, the rapid test is a screen, not a rule-out: a negative result does not by itself exclude streptococcal pharyngitis, and whether a culture is added as a reflex varies by setting and population.
A third layer is usually invisible to the clinic. A specimen sent on rather than read at the chair must survive transport and satisfy an acceptance standard, and that is where the two rulebooks part company.
Is a rapid strep test regulated the same way in Canada and the US?
No. The assay may be the same, but the pathway that lets a site run it is not.
In the United States, group A Streptococcus is included in the FDA list of waived analytes. A test cleared for that analyte can be performed under a CLIA Certificate of Waiver, the lightest tier of the CLIA framework, which does not carry the personnel and quality-system commitments of a moderate- or high-complexity certificate. That is why rapid strep testing is routine in US primary care and urgent care.
In Canada, in vitro diagnostic devices are regulated federally through the Medical Devices Regulations, which defines an in vitro diagnostic device as a device intended to be used in vitro for the examination of specimens taken from the body. A device needs a licence before it can be imported or sold, and the class assigned to it sets the evidence the manufacturer must file. There is no federal "waived" tier; the operating side is provincial, handled through the laboratory licensing regime of the province where testing happens.
| Item | Canada | United States |
|---|---|---|
| Federal device pathway | Device licence under the Medical Devices Regulations (SOR/98-282) | Cleared test; group A Streptococcus is a waived analyte |
| Clinic-run point-of-care testing | Where the provincial laboratory licence and the labelling allow it | Under a CLIA Certificate of Waiver |
| Specimen transport law | Transportation of Dangerous Goods Regulations | 49 CFR hazardous materials regulations |
| Category B packaging standard | CAN/CGSB-43.125, Type P650 | 49 CFR 173.199 triple packaging |
| Package marking | Category B mark | UN3373 diamond plus "Biological substances, Category B" |
A Canadian clinic cannot copy a US point-of-care programme wholesale. The assay is portable; the licence is not.
Does a throat swab have to be packaged differently in Canada than in the US?
Yes, and the difference sits in two rulebooks written in two design languages.
Canada treats the shipment as dangerous goods. Section 5.16(1) of the Transportation of Dangerous Goods Regulations says a person must not offer for transport, handle or transport dangerous goods included in Category A or Category B of Class 6.2, Infectious Substances, unless the goods are in a means of containment manufactured, selected and used in accordance with CAN/CGSB-43.125. For a Category B shipment the relevant type is Type P650, which the same regulations define by reference to CGSB-43.125, or to UN Packing Instruction P650 for packaging made outside Canada.
The United States treats the same shipment as a hazardous material. Under 49 CFR 173.199, a Category B infectious substance must be in a triple packaging of a primary receptacle, a secondary packaging and a rigid outer packaging. The primary receptacle must be packed so it cannot break, be punctured or leak into the secondary packaging under normal transport conditions. The package must pass a drop test at a height of at least 1.2 m without leakage from the primary receptacle, and at least one surface of the outer packaging must measure no less than 100 mm by 100 mm. The UN3373 square-on-point mark and the proper shipping name must both appear on the outer packaging.
| Item | Canada | United States |
|---|---|---|
| Instrument | Transportation of Dangerous Goods Regulations, SOR/2001-286 | 49 CFR Part 173, subpart E |
| Headline requirement | Means of containment made, selected and used to CAN/CGSB-43.125 | Triple packaging: primary, secondary, rigid outer |
| Named type for Category B | Type P650 | Not named; performance-based |
| Shock requirement | Set by the CGSB standard | Drop test at 1.2 m, no leakage |
| Marking | Category B mark, instead of the Class 6.2 label | UN3373 diamond plus "Biological substances, Category B" |
A clinic that ships swabs across the border, or buys packaging from a US catalogue, has to check which rulebook the packaging certificate speaks to: a bag sold as 95 kPa compliant is not automatically a Type P650 means of containment, and a Type P650 package is not automatically documented against the 49 CFR drop test.
What makes a rapid strep specimen unacceptable when it reaches the lab?
Public Health Ontario publishes the acceptance criteria its laboratories apply. Three of them carry the most weight for a swab that travels.
Packaging. The specimen packaging must meet the minimum Transportation of Dangerous Goods packaging requirements. This is a Canada-specific hook: the criterion points at a federal statute, and a submission arriving in a plain envelope fails on that clause alone.
Integrity. The specimen must not be leaking. This quietly disqualifies shipments assembled in a hurry, especially where the outer packaging is re-used or the absorbent material left out.
Identity. This is the strictest. Containers must be labelled with the patient's full name, or a unique code for anonymous testing, plus a second unique identifier such as date of birth or health card number, the date of collection, and the collection time for time-sensitive tests. Every field of the general test requisition must be completed, and the health card number on the requisition must match the specimen label. Where a critical specimen has identifiers that are missing, incomplete or conflicting between specimen and requisition, a signed waiver from the submitting health care provider is required before the specimen will be processed and reported. Without it, the test is cancelled.
Conflicting identifiers surprise clinics most often: a swab labelled with a nickname, or a requisition differing from the label, is a defined trigger for a waiver or a cancellation.
| Failure mode | Criterion | Fix |
|---|---|---|
| Packaging below the TDG minimum | Packaging must meet the federal TDG packaging requirements | Use packaging documented to CAN/CGSB-43.125 / Type P650 |
| Leaking specimen | The specimen must not be leaking | Add absorbent, seal the primary receptacle, inspect before dispatch |
| Missing identifier | Full name or unique code plus a second identifier and collection date | Print labels; no nicknames or initials |
| Conflicting identifiers | A conflict requires a signed waiver, or the test is cancelled | Cross-check label against requisition before the courier arrives |
Which collection consumables does a throat swab station actually need?
The list is short, but each item carries a specification a buyer should be able to point at.
- Tongue depressors. Needed to hold the tongue down while the posterior pharynx and tonsils are swabbed. Birch tongue depressors are specified by thickness in millimetres and by case format.
- Transport bags for onward shipment. This is where the CGSB and 49 CFR requirements land. A 95 kPa specimen transport bag has to be part of a packaging system documented against the applicable standard, with a separate documentation pouch so the requisition never sits against the specimen.
- Primary receptacles and transport tubes. The container holding the swab is the primary receptacle in the packaging chain; its closure and its resistance to puncture by the swab shaft keep the secondary packaging clean. A three-wall specimen transport bag is the usual choice where the requisition must travel outside the specimen compartment.
- Labels and requisitions. The identifier rules are only as good as the label stock and the pre-printed requisition.
- Gloves and hand hygiene supplies. A throat swab brings the collector within a cough of the patient, so glove selection is about fit and change frequency rather than chemical resistance.
- A labelled staging area. Swabs that travel need a defined staging point so they are not left on a counter.
For a clinic or laboratory buying these lines together, the ordering route matters as much as the item list.
Does the confirmation step differ, and does it change what you draw?
The rapid test answers one question only. If the result is negative and the clinical picture still suggests streptococcal pharyngitis, a throat culture is the usual follow-up, taking days rather than minutes. That reflex belongs to the clinician and the local protocol.
Where the confirmation pathway touches a blood draw, an old collection rule becomes relevant. When more than one tube is filled in a single venipuncture, the order of draw determines whether additives from one tube can carry over into the next. The Clinical and Laboratory Standards Institute sets that order and adds a warning that is easy to miss: plastic serum tubes containing a clot activator may cause interference in coagulation testing, and only blood culture tubes, glass nonadditive serum tubes, or plastic serum tubes without a clot activator may be collected before the coagulation tube.
The familiar "colours in order" summary is therefore not enough. If the visit includes a coagulation tube and the serum tube ahead of it is a plastic tube with a clot activator, the sequence itself can interfere with the coagulation result, and no downstream laboratory can fix that.
Sources
- CLSI, Order of Blood Draw Tubes and Additives
- CLSI, standards programme
- Public Health Ontario, Specimen Acceptance Criteria
- Public Health Ontario, Test Information Index
- Public Health Ontario, Streptococcus pyogenes (GAS) Typing
- Public Health Ontario, Kit and Test Ordering Instructions
- TDG Regulations, SOR/2001-286
- Medical Devices Regulations, SOR/98-282
- 49 CFR 173.199, Category B infectious substances
- FDA, CLIA waived analytes
- Minnesota Department of Health, Streptococcal Disease
- Canadian General Standards Board
- WHO, Laboratory Biosafety Manual, 4th edition
- WHO, antimicrobial resistance portal
- CLSI, about the institute
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers account setup and case pricing, and the B2B wholesale collection lists the lines stocked for institutional buyers. Sites that also run an in-house sterilizer can start with the biological indicator 5-pack trial.
Related reading
- Setting up a throat culture tray: supplies, labelling and storage
- Does TDG apply to specimen collection in Canada?
- Choosing 95 kPa specimen bags: sizes and absorbent pads
- Cutting sample rejection rates: six failure modes
- Diagnostic laboratory supply checklist
Frequently Asked Questions
Is a rapid strep test the same test in Canada and the US?
The assay chemistry is the same class of rapid antigen detection test. What differs is the route that lets a site run it: in the United States, group A Streptococcus is a waived analyte under CLIA, so a cleared test can be run under a Certificate of Waiver, while in Canada the test is an in vitro diagnostic device requiring a device licence and the site is licensed provincially.
Does a throat swab have to be packaged differently in Canada?
Yes. A Category B infectious substance must be in a means of containment manufactured, selected and used in accordance with CAN/CGSB-43.125, with Type P650 packaging for the Category B case, and Public Health Ontario's acceptance criteria require packaging to meet the minimum federal TDG requirements.
What is the US packaging requirement for the same shipment?
A Category B infectious substance must be packaged in triple packaging made up of a primary receptacle, a secondary packaging and a rigid outer packaging. It must survive a drop test at a height of at least 1.2 m without leakage, and must display the UN3373 square-on-point mark with the words Biological substances, Category B.
Why would a rapid strep specimen be cancelled by the laboratory?
The most common reason is identifier failure. Where a critical specimen has identifiers that are missing, incomplete or conflicting between specimen and requisition, a signed waiver is required before the specimen will be processed and reported; without it the test is cancelled. A leaking specimen and packaging below the TDG minimum are the other two drivers.
Which consumables does a throat swab station need?
Tongue depressors, transport bags documented against the applicable packaging standard, a primary receptacle or transport tube for the swab, labels and pre-printed requisitions carrying every mandated field, gloves, and a defined staging area for swabs waiting to be read or shipped.
Does a negative rapid strep test rule out infection?
No. A rapid antigen test is a screen, and a negative result does not by itself exclude streptococcal pharyngitis. Whether a culture is added as a reflex depends on the clinician, the population and the local protocol.
How does the order of draw matter for a throat swab visit?
It matters when the same visit also includes a venipuncture, for example a blood sample for a streptococcal complication. Plastic serum tubes containing a clot activator may cause interference in coagulation testing, and only blood culture tubes, glass nonadditive serum tubes, or plastic serum tubes without a clot activator may be collected before the coagulation tube.
CliniEco Medical supplies specimen transport packaging, tongue depressors, examination gloves and the wider diagnostic consumable lines described in this article. Health Canada MDEL #35334. This article is written for laboratory, clinic and procurement professionals and is not clinical guidance; specimen acceptance decisions belong to the receiving laboratory.
0 commentaire